Who owns AN2 THERAPEUTICS INC?
- Ticker: ANTX
- CUSIP Number: 037326105
Tip: Access positions for across all investors
Analyze quarterly positions in An2 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of An2 Therapeutics stock
Who bought or sold AN2 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 3.2M | $15M | 0% | Jun 2026 |
|
| Commodore Capital | 2.9M | $14M | 26% | Jun 2026 |
|
| Millennium Management | 2.3M | $11M | 4% | Jun 2026 |
|
| BlackRock | 1.7M | $8.1M | 422% | Jun 2026 |
|
| Spruce Street Capital | 1.7M | $8.0M | 100% | Jun 2026 |
|
| Almitas Capital | 1.5M | $7.1M | -1% | Jun 2026 |
|
| Vanguard Capital Management | 1.2M | $6.0M | 23% | Jun 2026 |
|
| Adage Capital Partners GP | 1.0M | $4.8M | 0% | Jun 2026 |
|
| Citadel Advisors | 952k | $4.6M | 513% | Jun 2026 |
|
| Boxer Capital Management | 749k | $3.6M | 0% | Jun 2026 |
|
| Geode Capital Management | 698k | $3.4M | 144% | Jun 2026 |
|
| SummitTX Capital | 598k | $2.9M | 100% | Jun 2026 |
|
| Balyasny Asset Management | 556k | $2.7M | 100% | Jun 2026 |
|
| Stonepine Capital Management | 552k | $2.7M | -23% | Jun 2026 |
|
| Ameriprise Financial | 537k | $2.6M | -23% | Jun 2026 |
|
| Sio Capital Management | 530k | $2.6M | -19% | Jun 2026 |
|
| Ally Bridge Group | 526k | $2.5M | 0% | Jun 2026 |
|
| Prosight Management | 475k | $2.3M | -8% | Jun 2026 |
|
| Woodline Partners | 460k | $2.2M | -54% | Jun 2026 |
|
| State Street Corporation | 312k | $1.5M | 170% | Jun 2026 |
|
| Northern Trust | 215k | $1.0M | 398% | Jun 2026 |
|
| Seven Fleet Capital Management | 209k | $1.0M | 5% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 197k | $953k | 43% | Jun 2026 |
|
| Vanguard Portfolio Management | 180k | $869k | 100% | Jun 2026 |
|
| Landscape Capital Management | 167k | $810k | -44% | Jun 2026 |
|
| Bank of America Corporation | 146k | $706k | -63% | Jun 2026 |
|
| Renaissance Technologies | 130k | $628k | -35% | Jun 2026 |
|
| Goldman Sachs Group | 88k | $426k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 76k | $368k | 100% | Jun 2026 |
|
| UBS Group | 74k | $359k | 21% | Jun 2026 |
|
| Walleye Trading Advisors | 72k | $349k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 68k | $328k | 100% | Jun 2026 |
|
| Charles Schwab Investment Management | 64k | $311k | 100% | Jun 2026 |
|
| Sixth Street Partners Management Company | 64k | $311k | 100% | Jun 2026 |
|
| Bridgeway Capital Management | 60k | $290k | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 59k | $285k | 324% | Jun 2026 |
|
| Captrust Financial Advisors | 40k | $194k | 0% | Jun 2026 |
|
| Velan Capital Investment Management | 40k | $194k | 100% | Jun 2026 |
|
| Nuveen | 35k | $171k | 100% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 26k | $125k | 100% | Jun 2026 |
|
| Rhumbline Advisers | 24k | $118k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 22k | $108k | 100% | Jun 2026 |
|
| Two Sigma Investments | 16k | $77k | 100% | Jun 2026 |
|
| Invesco | 14k | $67k | 100% | Jun 2026 |
|
| LPL Financial | 12k | $60k | 100% | Jun 2026 |
|
| Mirae Asset Global Etfs Holdings | 12k | $59k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 11k | $55k | 100% | Jun 2026 |
|
| Bronte Capital Management Pty | 11k | $53k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 10k | $49k | -66% | Jun 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 8.6k | $42k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 7.3k | $36k | 0% | Jun 2026 |
|
| Barclays | 5.5k | $27k | 1273% | Jun 2026 |
|
| New York State Common Retirement Fund | 5.0k | $24k | 100% | Jun 2026 |
|
| Legal & General Group | 2.6k | $12k | 100% | Jun 2026 |
|
| Summit Investment Advisors | 2.4k | $12k | 100% | Jun 2026 |
|
| Russell Investments | 2.1k | $10k | 100% | Jun 2026 |
|
| Tower Research Capital | 1.8k | $8.7k | 215% | Jun 2026 |
|
| Royal Bank of Canada | 938.00 | $5.0k | 100% | Jun 2026 |
|
| State of Wyoming | 603.00 | $3.2k | 100% | Sep 2026 |
|
| Sterling Capital Management | 562.00 | $3.0k | 16% | Sep 2026 |
|
| Federated Investors | 449.00 | $2.2k | -95% | Jun 2026 |
|
| Advisor Group Holdings | 300.00 | $1.5k | 0% | Jun 2026 |
|
| SBI Securities | 201.00 | $1.1k | 0% | Sep 2026 |
|
| GAMMA Investing | 191.00 | $1.0k | 100% | Sep 2026 |
|
| Fortitude Family Office | 90.00 | $478.998000 | 100% | Sep 2026 |
|
| FMR | 61.00 | $295.002100 | 100% | Jun 2026 |
|
| SJS Investment Consulting | 36.00 | $191.998800 | 100% | Sep 2026 |
|
| Root Financial Partners | 24.00 | $127.999200 | 100% | Sep 2026 |
|
| Caitong International Asset Management | 13.00 | $69.000100 | -95% | Sep 2026 |
|
Who sold out of An2 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of Nova Scotia | Mar 2026 | 459k | $1.6M |
| Jane Street | Mar 2026 | 304k | $1.0M |
| Cantor Fitzgerald, L. P. | Mar 2026 | 200k | $684k |
| Centiva Capital | Mar 2026 | 75k | $257k |
| Persistent Asset Partners | Mar 2026 | 38k | $131k |
| Hudson Bay Capital Management | Mar 2026 | 35k | $118k |
| Hrt Financial | Mar 2026 | 33k | $112k |
| Qube Research & Technologies | Mar 2026 | 24k | $83k |
| XTX Topco | Mar 2026 | 22k | $77k |
| Marshall Wace | Mar 2026 | 18k | $61k |
| OMERS Administration Corporation | Mar 2026 | 16k | $54k |
| Private Advisor | Mar 2026 | 13k | $43k |